2[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
3[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
4[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
5[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.
6[7]Sehetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl, 1998, 66: 96-101.
7[8]Okajima K. Clinical revelevance of determination of plasma AT Ⅲ and α2 antiplasmin activities in patients with DIC application of the molecularmarkers for the analysis of pathophysiology of DIC. Rinsho Byori,1994, 42 (1): 45-55.
8[9]Rocha E, Paramo JA, Montes R, et al. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica, 1998, 83 ( 11 ):1024-1037.
9[2]Violi F,Ferro D,Baili S,et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis[J]. Gastroenterology, 1995,109 (2) :531 ～ 539.
10[3]Olas B, Wachowicz B, Mielicki WP. Role of phosphoinositide kinase in adhesion of platelets to fibrinogen stimulated by cancer procoagulant [J]. Platelets ,2001,12 (7) :431 ～ 435.
3Palumbo J S, Kombrinck KW, Drew AF, et al. Fibrinogen is an im- portant determinant of the metastatic potential of circulating tumor cells[J]. Blood ,2000,96(10) :3302 -3309.
4Heino Biology of tumor Cell invasion : interplay of tumor cell ad- hesion and matrix degradation [ J ]. Int J cancer, 1996,65 ( 2 ) : 717 - 722.
5Palumbo J S, Potter JM, Kaplan LS, et al. Spontaneous hematoge- nous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen - deficient mice [J]. Cancer Res.2002,62 C 23 ) : 6966 - 6972.
6Piccioli A. Cancer and Venous thromboemolism [ J ]. Am Heart , 1996,132(10) :850 -855.
